Ind Swift Lab secures EDQM certification for Clarithromycin
Mumbai, Mar 28 (UNI) Ind Swift Laboratories has received the EDQM (European Directorate for the Quality of Medicines) certification for its key bulk drug Clarithromycin.
This is the second significant certification which the company has received within a short span of time, a company release here said.
The certification can be used by the manufacturers of pharmaceutical products in their applications for marketing authorisation to demonstrate the compliance of the substance used, with the monographs of the European Pharmacopoeia.
UNI GC GK VKG1330